NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Cognitive Muscular Therapy for Patients With Long-COVID and Breathing Pattern Disorder

CompletedNA

Sponsor: University of Salford

Conditions: Long COVID, Respiratory Disease

Interventions: Cognitive Muscular Therapy, Breathing visualisation

Countries: United Kingdom

The aim of the study is to test a treatment known as "Cognitive Muscular Therapy (CMT)" for reducing breathlessness and improving autonomic function in patients with long-COVID.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Above 18 years old
* Experience moderate/severe breathlessness, quantified using the Modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) scale.
* Speak and understand English sufficiently to read the information sheet and sign the consent form
* Ability to stand without any assistive device for at least 20 minutes (to ensure sufficient capacity to complete the intervention)

Exclusion Criteria:

* Dementia or other major cognitive impairment
* BMI \>32 (as increased subcutaneous fat prevents use of breathing measurement system)
* Current smoker or smoked regularly within last 6 months
* Any cardiorespiratory disease that requires medical intervention (except asthma management)
* Currently receiving physiotherapy-based treatment for LC or breathing pattern disorder
* Significant respiratory co-morbidity (e.g. COPD, uncontrolled Asthma)

Locations (1)

Manchester, Greater Manchester, United Kingdom